Core Viewpoint - Movano Health has received a delisting notice from Nasdaq due to non-compliance with the minimum bid price requirement and late filing of its Form 10-Q for the quarter ended March 31, 2025 [1][2]. Group 1: Delisting Notice Details - The company was notified on July 7, 2025, that its common stock's closing bid price had fallen below $1.00 per share for 30 consecutive trading days, violating the Bid Price Requirement [2]. - The company is not eligible for any compliance period due to a reverse stock split that occurred within the prior year [2]. - Movano Health plans to request a hearing before a Nasdaq Hearings Panel to contest the delisting and intends to seek an extended stay of suspension during the hearings process [1][3]. Group 2: Company Background - Movano Health, founded in 2018, focuses on developing healthcare solutions that provide medical-grade data through wearable devices [4]. - The company's technologies aim to proactively monitor and manage health outcomes across various patient populations [5].

Fourth Quarter Revenue Totaled $119.2 Million, Representing Year-over-Year Growth of 6%Fourth Quarter GAAP Net Loss of $18.8 Million and GAAP EPS of ($0.18); Fourth Quarter Non-GAAP Adjusted Net Income1 of $10.8 Million and Non-GAAP Adjusted EPS1 of $0.10Fourth Quarter Non-GAAP Adjusted EBITDA2 Totaled $20.5 Million, Representing Year-over-Year Growth of 66%Fiscal Year 2025 Revenue Totaled $490.5 Million; Fiscal Year 2025 GAAP Net Loss of $92.1 Million; Fiscal Year 2025 Non-GAAP Adjusted EBITDA2 Totaled $72 ...

Core Viewpoint - Movano Health has received a notice from Nasdaq regarding non-compliance with listing rules due to the failure to file its Form 10-Q for the quarter ended March 31, 2025, which was due on May 15, 2025 [1][2]. Group 1: Compliance and Regulatory Actions - The company has 60 calendar days, until July 21, 2025, to submit a plan to regain compliance with Nasdaq's Listing Rule [2]. - If Nasdaq accepts the compliance plan, the company may have up to 180 additional days, until November 11, 2025, to file the Form 10-Q [2]. Group 2: Company Overview - Movano Health, founded in 2018, is focused on developing healthcare solutions that provide medical-grade data through wearable devices [3]. - The company's devices aim to deliver trusted health data and insights to both consumers and enterprises, enhancing health monitoring and management [4].

Core Viewpoint - Digital Turbine (APPS) is expected to report a decline in earnings for the fourth quarter of fiscal 2025, with a consensus estimate of 5 cents per share, reflecting a 58.33% decrease from the previous year [1] Group 1: Earnings Performance - The Zacks Consensus Estimate for fiscal fourth-quarter earnings is unchanged over the past 30 days, indicating a significant decline compared to the year-ago quarter [1] - Digital Turbine has consistently beaten the Zacks Consensus Estimate in the last four quarters, with an average surprise of 281.67% [1] Group 2: Revenue Growth Factors - Strong international On-Device Solutions (ODS) momentum is expected to have contributed to revenue growth, following a 100% year-over-year revenue surge in the third quarter [2] - The company has expanded its global device partnerships, enhancing international revenue per device through collaborations with Motorola, Nokia, and T-Mobile US [3] Group 3: Market Dynamics - Despite soft device sales in the U.S., Digital Turbine has made significant progress internationally through partnerships with various companies, which is expected to support growth in the upcoming quarter [4] - The transition from waterfall to SDK bidding is anticipated to negatively impact performance, disrupting legacy Demand-Side Platforms (DSPs) and slowing down exchange monetization [5] Group 4: Challenges - Continued softness in U.S. device volumes is expected to pressure the company, offsetting growth opportunities in international markets [6]

LIBERTY LAKE, Wash., May 01, 2025 (GLOBE NEWSWIRE) -- Itron, Inc. (NASDAQ: ITRI), which is innovating the way utilities and cities manage energy and water, announced today financial results for its first quarter ended March 31, 2025. Key results for the quarter include (compared with the first quarter of 2024): Revenue of $607 million, increased 1%;Gross profit of $217 million, increased 6%;GAAP net income attributable to Itron, Inc. of $65 million, increased $14 million;GAAP diluted earnings per share of $ ...